Active, not recruitingPHASE2, PHASE3NCT04227483

Deflazacort Vs. Prednisolone in Acute-stage ABPA

Studying Allergic bronchopulmonary aspergillosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Intervention
Deflazacort(drug)
Enrollment
150 enrolled
Eligibility
18-65 years · All sexes
Timeline
20202025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04227483 on ClinicalTrials.gov

Other trials for Allergic bronchopulmonary aspergillosis

Additional recruiting or active studies for the same condition.

See all trials for Allergic bronchopulmonary aspergillosis

← Back to all trials